Global Anti-Inflammatory Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Indiction;

Arthritis - Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Gout, Respiratory Diseases - Asthma and Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Psoriasis and Inflammatory Bowel Disease (IBD) - Crohn's Disease and Ulcerative Colitis, Other Inflammatory Diseases.

Segmented by Drug Class;

Anti-inflammatory Biologics, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids and Other Anti-Inflammatory Drugs.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn422061077 Published Date: April, 2024 Updated Date: May, 2024
Download Free Sample NowDownload Free Sample Now

Introduction

Global Anti-Inflammatory Therapeutics Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 74.4
2021 81.4
2022 93.3
2023 98.3
2024 100.7
2025 110.9
2026 117.1
2027 135.5
2028 138.7
2029 150.9
2030 151.4

In the year 2023, the Global Anti-Inflammatory Therapeutics Market was valued at USD 78,946.01 million. The size of this market is expected to increase to USD 113,854.20 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Indiction
    2. Market Snapshot, By Drug Class
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Anti-Inflammatory Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Incidences Of Autoimmnue And Respiratory Conditions:
        2. New Drugs in Pipeline
        3. Increasing Adoption Rate Of Anti-Inflammatory Drugs
      2. Restraints
        1. Side Effects Of Anti-Inflammtory Drugs
        2. Patenet Expiries
      3. Opportunities
        1. Developing Biosimilars For The Existing Drugs
        2. Tapping The Emerging Markets In Developing Regions
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Anti-Inflammatory Therapeutics Market, By Indiction, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Arthritis
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Rheumatoid Arthritis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Osteoarthritis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Ankylosing Spondylitis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. Psoriatic Arthritis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. Gout
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Respiratory Diseases
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Asthma
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Chronic Obstructive Pulmonary Disease (COPD)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Multiple Sclerosis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Psoriasis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Inflammatory Bowel Disease (IBD)
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Crohn's Disease
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Ulcerative Colitis
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Other Inflammatory Diseases
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Anti-Inflammatory Therapeutics Market, By Drug Class, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Anti-inflammatory Biologics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Corticosteroids
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Other Anti-Inflammatory Drugs
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Anti-Inflammatory Therapeutics Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Indiction, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. AbbVie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Johnson & Johnson
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Merck & Co., Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Hoffmann-La Roche AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Eli Lily and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. AstraZeneca PLC.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Amgen Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Anti-Rheumatics
Global Anti-Rheumatics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-Rheumatics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Anti-malarial Drugs
Global Anti-malarial Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-malarial Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Anti-Neprilysin
Global Anti-Neprilysin Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Anti-Neprilysin Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Antiparasitic Drugs
Global Antiparasitic Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Antiparasitic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...